| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1055-9965.EPI-08-0528 |
| P698 | PubMed publication ID | 18990744 |
| P2093 | author name string | Hiroshi Araki | |
| Tomohiro Kato | |||
| Hisataka Moriwaki | |||
| Hirota Fujiki | |||
| Masahito Shimizu | |||
| Masami Suganuma | |||
| Yasushi Fukutomi | |||
| Kazuo Nagura | |||
| Mitsuo Ninomiya | |||
| P433 | issue | 11 | |
| P921 | main subject | tea | Q6097 |
| P304 | page(s) | 3020-3025 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. | |
| P478 | volume | 17 |
| Q89686521 | (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells |
| Q41446435 | (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis |
| Q48648973 | A Phytochemical-Sensing Strategy Based on Mass Spectrometry Imaging and Metabolic Profiling for Understanding the Functionality of the Medicinal Herb Green Tea. |
| Q28393278 | A multi-targeted approach to suppress tumor-promoting inflammation |
| Q50196768 | Adsorption of galloyl catechin aggregates significantly modulates membrane mechanics in the absence of biochemical cues |
| Q47146612 | Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study |
| Q57169953 | Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer |
| Q39030337 | Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells |
| Q38879552 | Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents |
| Q28079722 | Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins |
| Q33451474 | Can green tea do that? A literature review of the clinical evidence |
| Q50078680 | Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells. |
| Q28076334 | Cancer Preventive Activities of Tea Catechins |
| Q37871559 | Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. |
| Q38031118 | Cancer prevention by targeting angiogenesis |
| Q33693371 | Cancer prevention by tea: animal studies, molecular mechanisms and human relevance |
| Q38988558 | Catechins and Its Role in Chronic Diseases |
| Q38018851 | Challenging the effectiveness of green tea in primary and tertiary cancer prevention |
| Q42038428 | Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG-The Role of EGFR Signaling and "Lipid Raft". |
| Q26995915 | Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities |
| Q37776083 | Chemoprevention of head and neck cancer with green tea polyphenols |
| Q26772302 | Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents |
| Q45729653 | Chemopreventive efficacy of green tea drinking against 1,2-dimethyl hydrazine-induced rat colon carcinogenesis |
| Q35381561 | Chemopreventive potential of green tea catechins in hepatocellular carcinoma |
| Q37565172 | Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth |
| Q37822700 | Diet, obesity and cancer. |
| Q38137099 | Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives |
| Q26852978 | Does tea prevent cancer? Evidence from laboratory and human intervention studies |
| Q90050994 | Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention |
| Q39747640 | Emerging role of bioflavonoids in gastroenterology: Especially their effects on intestinal neoplasia. |
| Q50528394 | Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. |
| Q52926605 | Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation. |
| Q39475732 | Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells |
| Q37085982 | Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer |
| Q38681165 | Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. |
| Q60960773 | Flavonoids and Colorectal Cancer Prevention |
| Q37198232 | Going Green: The Role of the Green Tea Component EGCG in Chemoprevention |
| Q58693136 | Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth |
| Q89968586 | Green tea (Camellia sinensis) for the prevention of cancer |
| Q34270754 | Green tea and lung cancer: a systematic review. |
| Q38983081 | Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression |
| Q43434634 | Green tea consumption and incidence of colorectal cancer |
| Q28390952 | Green tea extract selectively targets nanomechanics of live metastatic cancer cells |
| Q83381740 | Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells |
| Q36002120 | Homeostatic imbalance and colon cancer: the dynamic epigenetic interplay of inflammation, environmental toxins, and chemopreventive plant compounds |
| Q47133638 | Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. |
| Q35568151 | Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway |
| Q38609163 | Influences of Dietary and Other Factors on Xenobiotic Metabolism and Carcinogenesis-A Review Article in Memory of Dr. Allan H. Conney (1930-2013). |
| Q37067798 | Lessons learned from cancer prevention studies with nutrients and non-nutritive dietary constituents |
| Q30242061 | Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials |
| Q30919523 | Metabolic profiling-based data-mining for an effective chemical combination to induce apoptosis of cancer cells |
| Q26823107 | Natural compounds as anticancer agents: Experimental evidence |
| Q37825591 | New cancer treatment strategy using combination of green tea catechins and anticancer drugs |
| Q34635693 | Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis |
| Q38040323 | Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis |
| Q37882092 | Pharmacokinetic and chemoprevention studies on tea in humans |
| Q36349535 | Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus |
| Q33890604 | Phorbol esters in seed oil of Jatropha curcas L. (saboodam in Thai) and their association with cancer prevention: from the initial investigation to the present topics |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q33754774 | Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation |
| Q35261302 | Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds |
| Q33996086 | Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly populat |
| Q38767117 | Quantitative comparison of cancer and normal cell adhesion using organosilane monolayer templates: an experimental study on the anti-adhesion effect of green-tea catechins |
| Q33657615 | Recent scientific studies of a traditional chinese medicine, tea, on prevention of chronic diseases |
| Q33763749 | Steep your genes in health: drink tea. |
| Q38302024 | Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds |
| Q94187279 | Tannins of Constant Structure in Medicinal and Food Plants—Hydrolyzable Tannins and Polyphenols Related to Tannins |
| Q89906548 | Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer |
| Q50081265 | The Impact of Dietary Polyphenols on COX-2 Expression in Colorectal Cancer |
| Q35891865 | The effects of nutritional interventions on recurrence in survivors of colorectal adenomas and cancer: a systematic review of randomised controlled trials |
| Q28071416 | The human HSP70 family of chaperones: where do we stand? |
| Q42736021 | The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives |
| Q90335016 | Therapeutic potential of natural plant products and their metabolites in preventing radiation enteropathy resulting from abdominal or pelvic irradiation |
| Q35250910 | Tumor angiogenesis as a target for dietary cancer prevention |
| Q38113724 | Tumor promoters: from chemicals to inflammatory proteins |
| Q26765196 | Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials |
| Q84997149 | [Colorectal cancer prevention by flavonoids] |
Search more.